Houston, Texas — According to state and local development sources, Avance Biosciences plans to invest $1,200,000.00 to build out 16,912 square feet of new space in Houston. The company plans to occupy the new space at 5500 North West Central Dr. Suite 100 in Houston, on or about May 1, 2025. According to the company website Were an advanced genomic services company offering assays compliant with FDA and EPA enforced regulations to assist our customers in their regulatory submissions. Combined, our company’s founders possess more than a century of experience in the industry. Throw in a team of leading scientists who have designed and executed countless studies satisfying US, European, and Japanese regulatory agencies, and you’ve got a powerhouse that has already met the needs of over a hundred pharmaceutical and crop science companies around the world. We offer DNA sequencing, quantitative PCR, and other molecular biology and microbiology techniques to support your cGMP/GLP submissions. For academic and industrial researchers, we also provide research-grade services.

To learn more about Avance Biosciences, visit http://www.avancebio.com/

Company Contact:
Xuening Huang, Chief Executive Officer
xuening.huang@avancebio.com
https://www.linkedin.com/in/xuening-huang-92b07b2/
713-849-3380

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.